Standout Papers

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patie... 1997 2026 2006 2016 4.6k
  1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. (1997)
    Howard A. Burris, Malcolm J. Moore et al. Journal of Clinical Oncology
  2. The Danish National Health Service Register (2011)
    John Sahl Andersen, Niels de Fine Olivarius et al. Scandinavian Journal of Public Health

Immediate Impact

1 by Nobel laureates 24 from Science/Nature 75 standout
Sub-graph 1 of 18

Citing Papers

The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Dietary methionine influences therapy in mouse cancer models and alters human metabolism
2019 StandoutNature
2 intermediate papers

Works of John Sahl Andersen being referenced

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 Standout

Author Peers

Author Last Decade Papers Cites
John Sahl Andersen 420 350 1565 4326 1506 59 6.5k
Anne‐Michelle Noone 365 412 1372 3267 1258 64 6.8k
Christie R. Eheman 384 349 1447 3838 935 46 7.2k
Holly L. Howe 599 488 1144 4051 1020 68 8.6k
Hannah K. Weir 274 514 1266 3806 1027 80 7.8k
Recinda Sherman 263 478 1049 3051 1163 56 6.6k
Vivien W. Chen 231 399 852 3453 1035 76 6.3k
Milena Sant 288 533 1344 4454 1172 127 8.1k
Harmon J. Eyre 521 255 1872 4100 763 91 8.3k
Harry Comber 250 372 912 3116 822 103 6.8k
Rosemary D. Cress 208 294 1007 3846 1376 126 6.7k

All Works

Loading papers...

Rankless by CCL
2026